Under real world EAP results Ryoncil is more effective than Rux but it is too small a sample .
Beancounters at insurers will take the cheaper option until we run a successful adult trial.
Perhaps that will be in Rux Refractory patients with Grade 3/4 - sooner the better.
Commercial realities setting in for some - like I said - wait for April 30 then July 30 for sales numbers before throwing the baby out with the bath water.
Company will need to update current state of insurance negotiations or we are going South .
All my brilliant opinions
only opinions
Reg
MSB Price at posting:
$2.80 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)